Variant report
Variant | nsv1062552 |
---|---|
Chromosome Location | chr19:43262970-43609987 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4843)
- CpG islands (count:2442)
- Chromatin interactive region (count:8)
- LncRNA region (count:49)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr19:43336349-43336838 | A549 | lung: | n/a | n/a |
2 | ATF3 | chr19:43355412-43355889 | A549 | lung: | n/a | n/a |
3 | ATF3 | chr19:43335307-43336092 | A549 | lung: | n/a | n/a |
4 | ATF3 | chr19:43335349-43336094 | A549 | lung: | n/a | n/a |
5 | ATF3 | chr19:43336336-43336928 | A549 | lung: | n/a | n/a |
6 | ATF3 | chr19:43355048-43355947 | A549 | lung: | n/a | n/a |
7 | BATF | chr19:43588401-43588710 | GM12878 | blood: | n/a | n/a |
8 | BATF | chr19:43552261-43552460 | GM12878 | blood: | n/a | chr19:43552319-43552330 |
9 | BATF | chr19:43552186-43552537 | GM12878 | blood: | n/a | chr19:43552319-43552330 |
10 | BATF | chr19:43302238-43302533 | GM12878 | blood: | n/a | chr19:43302344-43302355 |
11 | BATF | chr19:43271446-43271728 | GM12878 | blood: | n/a | n/a |
12 | BATF | chr19:43442962-43443231 | GM12878 | blood: | n/a | n/a |
13 | BATF | chr19:43591924-43592150 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr19:43361555-43361754 | GM12878 | blood: | n/a | n/a |
15 | BCL3 | chr19:43335242-43336126 | A549 | lung: | n/a | chr19:43335602-43335611 chr19:43335603-43335612 |
16 | BCL3 | chr19:43297507-43298116 | A549 | lung: | n/a | n/a |
17 | BCL3 | chr19:43402518-43403428 | A549 | lung: | n/a | n/a |
18 | BCL3 | chr19:43323095-43323355 | GM12878 | blood: | n/a | n/a |
19 | BCL3 | chr19:43354946-43356043 | A549 | lung: | n/a | n/a |
20 | BCL3 | chr19:43354910-43356058 | A549 | lung: | n/a | n/a |
21 | BCL3 | chr19:43336159-43337656 | A549 | lung: | n/a | chr19:43336227-43336234 |
22 | BCL3 | chr19:43335292-43335990 | A549 | lung: | n/a | chr19:43335602-43335611 chr19:43335603-43335612 |
23 | BCL3 | chr19:43336972-43337663 | A549 | lung: | n/a | n/a |
24 | BCL3 | chr19:43336292-43336877 | A549 | lung: | n/a | n/a |
25 | BHLHE40 | chr19:43355572-43355890 | A549 | lung: | n/a | n/a |
26 | BHLHE40 | chr19:43582147-43582203 | K562 | blood: | n/a | n/a |
27 | BHLHE40 | chr19:43427453-43427512 | GM12878 | blood: | n/a | n/a |
28 | BHLHE40 | chr19:43385480-43385517 | K562 | blood: | n/a | n/a |
29 | BRCA1 | chr19:43297623-43297950 | Hela-S3 | cervix: | n/a | n/a |
30 | BRCA1 | chr19:43265411-43265577 | Hela-S3 | cervix: | n/a | n/a |
31 | BRCA1 | chr19:43525934-43526309 | Hela-S3 | cervix: | n/a | n/a |
32 | BRCA1 | chr19:43436723-43436914 | Hela-S3 | cervix: | n/a | n/a |
33 | BRCA1 | chr19:43355288-43355847 | Hela-S3 | cervix: | n/a | n/a |
34 | CBX3 | chr19:43385505-43385738 | K562 | blood: | n/a | n/a |
35 | CBX3 | chr19:43385431-43385838 | K562 | blood: | n/a | n/a |
36 | CEBPB | chr19:43562801-43563050 | IMR90 | lung: | n/a | n/a |
37 | CEBPB | chr19:43525813-43526656 | Hela-S3 | cervix: | n/a | n/a |
38 | CEBPB | chr19:43562984-43563042 | A549 | lung: | n/a | n/a |
39 | CEBPB | chr19:43510146-43510361 | IMR90 | lung: | n/a | chr19:43510191-43510202 |
40 | CEBPB | chr19:43496486-43496642 | K562 | blood: | n/a | n/a |
41 | CEBPB | chr19:43582058-43582378 | Hela-S3 | cervix: | n/a | n/a |
42 | CEBPB | chr19:43329315-43329373 | K562 | blood: | n/a | chr19:43329341-43329352 |
43 | CEBPB | chr19:43345870-43346046 | IMR90 | lung: | n/a | n/a |
44 | CEBPB | chr19:43525800-43526621 | IMR90 | lung: | n/a | n/a |
45 | CEBPB | chr19:43402907-43403129 | Hela-S3 | cervix: | n/a | n/a |
46 | CEBPB | chr19:43516550-43516678 | K562 | blood: | n/a | n/a |
47 | CEBPB | chr19:43339173-43339354 | Hela-S3 | cervix: | n/a | n/a |
48 | CEBPB | chr19:43403099-43403104 | A549 | lung: | n/a | n/a |
49 | CEBPB | chr19:43265183-43265848 | IMR90 | lung: | n/a | n/a |
50 | CEBPB | chr19:43328228-43328417 | HepG2 | liver: | n/a | chr19:43328257-43328268 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:43514144-43514194 | GM12878 | blood: | n/a |
2 | chr19:43423176-43423226 | GM19239 | blood: | n/a |
3 | chr19:43514144-43514194 | GM12878 | blood: | n/a |
4 | chr19:43423176-43423226 | GM19239 | blood: | n/a |
5 | chr19:43587500-43587550 | Jurkat | blood: | n/a |
6 | chr19:43569592-43569642 | NT2-D1 | testis: | n/a |
7 | chr19:43588055-43588105 | Hela-S3 | cervix: | n/a |
8 | chr19:43423176-43423226 | HIPEpiC | eye: | n/a |
9 | chr19:43588069-43588119 | Caco-2 | colon: | n/a |
10 | chr19:43360755-43360805 | MCF10A-Er-Src | breast: | n/a |
11 | chr19:43588025-43588075 | Hela-S3 | cervix: | n/a |
12 | chr19:43423265-43423315 | SK-N-SH | brain: | n/a |
13 | chr19:43531821-43531871 | RPTEC | kidney: | n/a |
14 | chr19:43442484-43442534 | ProgFib | skin: | n/a |
15 | chr19:43442804-43442854 | NHDF-neo | bronchial: | n/a |
16 | chr19:43269877-43269927 | ovcar-3 | ovarian: | n/a |
17 | chr19:43361218-43361268 | GM12892 | blood: | n/a |
18 | chr19:43383799-43383849 | GM12892 | blood: | n/a |
19 | chr19:43385100-43385150 | GM06990 | blood: | n/a |
20 | chr19:43528994-43529044 | GM12892 | blood: | n/a |
21 | chr19:43588055-43588105 | HMEC | breast: | n/a |
22 | chr19:43528994-43529044 | ECC-1 | luminal epithelium: | n/a |
23 | chr19:43569592-43569642 | HRCEpiC | kidney: | n/a |
24 | chr19:43271058-43271108 | PrEC | prostate: | n/a |
25 | chr19:43423119-43423169 | K562 | blood: | n/a |
26 | chr19:43269877-43269927 | MCF-7 | breast: | n/a |
27 | chr19:43442693-43442743 | GM12878 | blood: | n/a |
28 | chr19:43271058-43271108 | HEK293 | kidney: | embryo |
29 | chr19:43530623-43530673 | HRPEpiC | eye: | n/a |
30 | chr19:43360755-43360805 | HIPEpiC | eye: | n/a |
31 | chr19:43271004-43271054 | A549 | lung: | n/a |
32 | chr19:43271112-43271162 | GM19239 | blood: | n/a |
33 | chr19:43383405-43383455 | RPTEC | kidney: | n/a |
34 | chr19:43423265-43423315 | AG04449 | skin: | fetal |
35 | chr19:43588055-43588105 | SK-N-MC | brain: | n/a |
36 | chr19:43528994-43529044 | PFSK-1 | brain: | n/a |
37 | chr19:43587500-43587550 | GM12878 | blood: | n/a |
38 | chr19:43383799-43383849 | NHDF-neo | bronchial: | n/a |
39 | chr19:43530623-43530673 | MCF10A-Er-Src | breast: | n/a |
40 | chr19:43531770-43531820 | RPTEC | kidney: | n/a |
41 | chr19:43531770-43531820 | HCT-116 | colon: | n/a |
42 | chr19:43360229-43360279 | ProgFib | skin: | n/a |
43 | chr19:43580600-43580650 | H1-hESC | embryonic stem cell: | embryo |
44 | chr19:43442809-43442859 | Caco-2 | colon: | n/a |
45 | chr19:43569592-43569642 | AG10803 | skin: | n/a |
46 | chr19:43442484-43442534 | HRCEpiC | kidney: | n/a |
47 | chr19:43588055-43588105 | AoSMC | blood vessel: | n/a |
48 | chr19:43385047-43385097 | AG09309 | skin: | n/a |
49 | chr19:43588025-43588075 | HRE | kidney: | n/a |
50 | chr19:43271112-43271162 | HPAEpiC | pulmonary alveolar: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:43523469..43524084-chr19:43531918..43532440,2 | MCF-7 | breast: | |
2 | chr19:43265768..43266290-chr19:43769932..43770473,2 | MCF-7 | breast: | |
3 | chr19:43197633..43198568-chr19:43280847..43281639,2 | K562 | blood: | |
4 | chr19:43523469..43524084-chr19:43531918..43532440,2 | MCF-7 | breast: | |
5 | chr19:43197647..43198196-chr19:43280850..43281744,2 | MCF-7 | breast: | |
6 | chr19:43297087..43297875-chr19:43423005..43423976,2 | MCF-7 | breast: | |
7 | chr19:43608137..43608719-chr19:43820621..43821519,2 | MCF-7 | breast: | |
8 | chr19:43531581..43532101-chr2:1136088..1136613,2 | MCF-7 | breast: |
(count:49 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PSG1-1 | chr19:43343520-43343530 | NONHSAT146988 |
2 | lnc-PSG2-1 | chr19:43586658-43586820 | NONHSAT066581 |
3 | lnc-PSG2-5 | chr19:43519268-43519426 | NONHSAT066577 |
4 | lnc-PSG1-1 | chr19:43341149-43341534 | NONHSAT066571 |
5 | lnc-PSG1-1 | chr19:43348511-43348765 | NONHSAT146988 |
6 | lnc-PSG2-5 | chr19:43514422-43514579 | NONHSAT066577 |
7 | lnc-PSG6-1 | chr19:43429925-43431729 | NONHSAT066573 |
8 | lnc-PSG1-1 | chr19:43349168-43349446 | NONHSAT146988 |
9 | lnc-PSG1-1 | chr19:43343447-43343530 | NONHSAT066571 |
10 | lnc-PSG6-1 | chr19:43441165-43441330 | NONHSAT066574 |
11 | lnc-PSG6-2 | chr19:43453655-43453909 | NONHSAT066575 |
12 | lnc-PSG6-1 | chr19:43439556-43439921 | NR_073194 |
13 | lnc-PSG2-2 | chr19:43575923-43576106 | NONHSAT066580 |
14 | lnc-PSG6-1 | chr19:43429925-43430179 | NR_073194 |
15 | lnc-PSG11-1 | chr19:43544526-43544780 | NONHSAT066579 |
16 | lnc-PSG2-2 | chr19:43576503-43576781 | NONHSAT066580 |
17 | lnc-PSG1-1 | chr19:43358101-43358466 | NONHSAT066571 |
18 | lnc-PSG1-1 | chr19:43343708-43343916 | NONHSAT066571 |
19 | lnc-PSG1-1 | chr19:43348511-43348765 | NONHSAT066571 |
20 | lnc-PSG8-1 | chr19:43289879-43290117 | NONHSAT066567 |
21 | lnc-PSG8-1 | chr19:43285358-43285449 | NONHSAT066567 |
22 | lnc-PSG2-5 | chr19:43514110-43514858 | NONHSAT066576 |
23 | lnc-PSG1-1 | chr19:43359708-43359870 | NONHSAT146988 |
24 | lnc-PSG1-1 | chr19:43343708-43343916 | NONHSAT146988 |
25 | lnc-PSG1-1 | chr19:43359708-43359870 | NONHSAT066571 |
26 | lnc-PSG2-4 | chr19:43521383-43521753 | NONHSAT066578 |
27 | lnc-PSG2-3 | chr19:43601248-43601512 | NONHSAT066582 |
28 | lnc-PSG6-3 | chr19:43372253-43372507 | NONHSAT066572 |
29 | lnc-PSG1-1 | chr19:43570669-43570753 | NONHSAT066570 |
30 | lnc-PSG2-2 | chr19:43587104-43587197 | NONHSAT066580 |
31 | lnc-PSG6-1 | chr19:43433594-43433872 | NR_073194 |
32 | lnc-PSG6-1 | chr19:43428286-43428976 | NONHSAT066573 |
33 | lnc-PSG6-2 | chr19:43454299-43454539 | NONHSAT066575 |
34 | lnc-PSG6-3 | chr19:43372908-43374797 | NONHSAT066572 |
35 | lnc-PSG6-1 | chr19:43430590-43430868 | NR_073194 |
36 | lnc-PSG11-1 | chr19:43545168-43545400 | NONHSAT066579 |
37 | lnc-PSG1-1 | chr19:43358101-43358466 | NONHSAT146988 |
38 | lnc-PSG1-1 | chr19:43349168-43349446 | NONHSAT066571 |
39 | lnc-PSG11-1 | chr19:43540021-43540112 | NONHSAT066579 |
40 | lnc-PSG2-5 | chr19:43511982-43512194 | NONHSAT066576 |
41 | lnc-PSG6-1 | chr19:43428284-43428976 | NR_073194 |
42 | lnc-PSG2-4 | chr19:43522922-43523199 | NONHSAT066578 |
43 | lnc-PSG6-1 | chr19:43441165-43441330 | NR_073194 |
44 | lnc-PSG2-1 | chr19:43585939-43586423 | NONHSAT066581 |
45 | lnc-PSG1-1 | chr19:43341149-43341602 | NONHSAT066570 |
46 | lnc-PSG6-3 | chr19:43370618-43371302 | NONHSAT066572 |
47 | lnc-PSG2-3 | chr19:43600608-43600855 | NONHSAT066582 |
48 | lnc-PSG8-1 | chr19:43290505-43290747 | NONHSAT066567 |
49 | lnc-PSG6-1 | chr19:43440309-43440647 | NONHSAT066574 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CEACAMP7 | TF binding region |
CEACAMP9 | TF binding region |
PSG8 | TF binding region |
PSG11 | TF binding region |
ENSG00000225877 | TF binding region |
PSG6 | TF binding region |
CEACAMP6 | TF binding region |
CEACAMP8 | TF binding region |
PSG1 | TF binding region |
PSG2 | TF binding region |
PSG7 | TF binding region |
PSG10P | TF binding region |
CEACAMP7 | CpG island |
CEACAMP9 | CpG island |
PSG8 | CpG island |
PSG11 | CpG island |
ENSG00000225877 | CpG island |
PSG6 | CpG island |
CEACAMP6 | CpG island |
CEACAMP8 | CpG island |
PSG1 | CpG island |
PSG2 | CpG island |
PSG7 | CpG island |
PSG10P | CpG island |
ENSG00000170848 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552215014 | chr19:43262975-43262976 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs182269674 | chr19:43262979-43262980 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs187455904 | chr19:43263008-43263009 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs554386608 | chr19:43263011-43263012 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs146228036 | chr19:43263016-43263017 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs537307649 | chr19:43263035-43263036 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs193255600 | chr19:43263038-43263039 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs563338278 | chr19:43263043-43263044 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs148417392 | chr19:43263068-43263069 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs371305028 | chr19:43263078-43263079 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs185441984 | chr19:43263122-43263123 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs553483407 | chr19:43263146-43263147 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs573423603 | chr19:43263147-43263148 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs542433870 | chr19:43263158-43263159 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs10407273 | chr19:43263161-43263162 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs531014388 | chr19:43263163-43263164 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs544862265 | chr19:43263166-43263167 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs150500838 | chr19:43263229-43263230 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs532117833 | chr19:43263264-43263265 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs551782177 | chr19:43263267-43263268 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs565432277 | chr19:43263268-43263269 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs528209112 | chr19:43263340-43263341 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs547887363 | chr19:43263348-43263349 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs567888651 | chr19:43263363-43263364 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs536870020 | chr19:43263369-43263370 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs543297280 | chr19:43263395-43263396 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs562032079 | chr19:43263404-43263405 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs557209038 | chr19:43263458-43263459 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs145691944 | chr19:43263465-43263466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539817501 | chr19:43263466-43263467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573285526 | chr19:43263472-43263473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535903132 | chr19:43263474-43263475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115953317 | chr19:43263481-43263482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190299359 | chr19:43263503-43263504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114518072 | chr19:43263508-43263509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78216544 | chr19:43263524-43263525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs578218884 | chr19:43263527-43263528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545382265 | chr19:43263536-43263537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112848329 | chr19:43263552-43263553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199831190 | chr19:43263589-43263590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs60227132 | chr19:43263600-43263601 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs147741322 | chr19:43263610-43263611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs114877390 | chr19:43263613-43263614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530712348 | chr19:43263628-43263629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544126034 | chr19:43263630-43263631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373621712 | chr19:43263639-43263640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192015480 | chr19:43263659-43263660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184081434 | chr19:43263660-43263661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7250007 | chr19:43263700-43263701 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs144774869 | chr19:43263703-43263704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Astrocytoma | 22246337 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Ependymoma | 20639864 | CNVD |
Autism | 19492091 | CNVD |
Ovarian cancer | 20800559 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Nicotine metabolism | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Melanoma | 20877625 | CNVD |
Ovarian cancer | 21240255 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Primary Severe Spermatogenic Failure | 20378930 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:43262600-43263200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr19:43262600-43264200 | Weak transcription | Placenta | Placenta |
3 | chr19:43263200-43264600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr19:43263400-43263600 | Enhancers | NHLF | lung |
5 | chr19:43263400-43267600 | Enhancers | NHDF-Ad | bronchial |
6 | chr19:43263600-43264400 | Weak transcription | NHLF | lung |
7 | chr19:43263600-43267600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr19:43264200-43264800 | Enhancers | Placenta | Placenta |
9 | chr19:43264200-43265000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr19:43264200-43267200 | Enhancers | Osteobl | bone |
11 | chr19:43264400-43265400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
12 | chr19:43264400-43266200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
13 | chr19:43264400-43267600 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr19:43264400-43267600 | Enhancers | NHLF | lung |
15 | chr19:43264600-43268000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr19:43264800-43265200 | Flanking Active TSS | Placenta | Placenta |
17 | chr19:43264800-43265400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr19:43264800-43265400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr19:43264800-43265800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
20 | chr19:43264800-43265800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
21 | chr19:43264800-43265800 | Enhancers | HSMM | muscle |
22 | chr19:43264800-43267400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
23 | chr19:43264800-43267600 | Enhancers | HMEC | breast |
24 | chr19:43264800-43267600 | Enhancers | NH-A | brain |
25 | chr19:43265000-43265800 | Enhancers | A549 | lung |
26 | chr19:43265000-43266000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
27 | chr19:43265000-43266400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
28 | chr19:43265000-43267400 | Enhancers | NHEK | skin |
29 | chr19:43265000-43267600 | Enhancers | Hela-S3 | cervix |
30 | chr19:43265200-43265400 | Enhancers | Esophagus | oesophagus |
31 | chr19:43265200-43265400 | Active TSS | Placenta | Placenta |
32 | chr19:43265200-43265400 | Enhancers | Pancreas | Pancrea |
33 | chr19:43265200-43267800 | Enhancers | HSMMtube | muscle |
34 | chr19:43265400-43266400 | Weak transcription | Esophagus | oesophagus |
35 | chr19:43265400-43266400 | Weak transcription | Pancreas | Pancrea |
36 | chr19:43265400-43266600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
37 | chr19:43265400-43266600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
38 | chr19:43265400-43266600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
39 | chr19:43265400-43266600 | Weak transcription | Placenta | Placenta |
40 | chr19:43265800-43266200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
41 | chr19:43265800-43266200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
42 | chr19:43265800-43266200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
43 | chr19:43265800-43266200 | Weak transcription | HSMM | muscle |
44 | chr19:43265800-43266400 | Weak transcription | A549 | lung |
45 | chr19:43266000-43267000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
46 | chr19:43266200-43266600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
47 | chr19:43266200-43266600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
48 | chr19:43266200-43267600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
49 | chr19:43266200-43267800 | Enhancers | HSMM | muscle |
50 | chr19:43266200-43268000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |